Discovery of Kaempferol, a Novel ADAM10 Inhibitor, as a Potential Treatment for Staphylococcus aureus Infection
Engineering · 2023-09 · 28 · 206-221
DOI: 10.1016/j.eng.2023.03.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Engineering, 2023-09. Verfasst von Tingting Wang und 8 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Host-directed therapy (HDT) is an emerging novel approach for treating multidrug-resistant Staphylococcus aureus (S. aureus) infection. Functioning as the indispensable specific cellular receptor for α-toxin (Hla), a-disintegrin and metalloproteinase 10 (ADAM10) is exploited to accelerate S. aureus infection through diverse mechanisms. The extraordinary contribution of ADAM10 to S. aureus pathogenesis renders it an attractive HDT target for combating S. aureus infection. Our study is the first to demonstrate the indispensable role of ADAM10 in S. aureus-induced necroptosis, and it enhances our knowledge of the role of ADAM10 in S. aureus infection. Using a fluorogenic substrate assay, we further identified kaempferol as a potent ADAM10 inhibitor that effectively protected mice from S. aureus infection by suppressing Hla-mediated barrier disruption and necroptosis. Collectively, our work presents a novel host-directed therapeutic strategy for using the promising candidate kaempferol to treat S. aureus infection and other diseases relevant to the disordered upregulation of ADAM10.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, T., Wang, J., Xu, X., Jiang, F., Lv, H., Qi, Q., Zhang, C., Lv, Q., & Deng, X. (2023). Discovery of Kaempferol, a Novel ADAM10 Inhibitor, as a Potential Treatment for Staphylococcus aureus Infection. Engineering, 28, 206-221. https://doi.org/10.1016/j.eng.2023.03.006
Vancouver
Wang T, Wang J, Xu X, Jiang F, Lv H, Qi Q, et al. Discovery of Kaempferol, a Novel ADAM10 Inhibitor, as a Potential Treatment for Staphylococcus aureus Infection. Engineering. 2023;28:206-221. doi:10.1016/j.eng.2023.03.006
BibTeX
@article{Wang2023,
author = {Wang, Tingting and Wang, Jianfeng and Xu, Xiangzhu and Jiang, Fan and Lv, Hongfa and Qi, Qinghui and Zhang, Can and Lv, Qianghua and Deng, Xuming},
title = {Discovery of Kaempferol, a Novel ADAM10 Inhibitor, as a Potential Treatment for Staphylococcus aureus Infection},
journal = {Engineering},
year = {2023},
volume = {28},
pages = {206--221},
doi = {10.1016/j.eng.2023.03.006}
}
EUVIMED